EXPERIMENTAL TUMOR ACTIVITY OF ADRIAMYCIN (NSC-123127)

被引:0
|
作者
GOLDIN, A [1 ]
JOHNSON, RK [1 ]
机构
[1] NCI,DIV CANC TREATMENT,LAB EXPTL CHEMOTHERAPY DRUG RES & DEV,BETHESDA,MD
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:137 / 145
页数:9
相关论文
共 50 条
  • [21] ADRIAMYCIN (NSC-123127) - MODE AND MECHANISM OF ACTION
    DIMARCO, A
    CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 91 - 106
  • [22] POLYCHEMOTHERAPY WITH ADRIAMYCIN (NSC-123127) IN BRONCHOGENIC CARCINOMA
    SELAWRY, OS
    CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 353 - 359
  • [23] PRELIMINARY PHARMACOKINETIC MODEL FOR ADRIAMYCIN (NSC-123127)
    HARRIS, PA
    GROSS, JF
    CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (04): : 819 - 825
  • [24] SOME OBSERVATIONS ON TOXICITY OF ADRIAMYCIN (NSC-123127)
    PHILIPS, FS
    GILLADOGA, A
    MARQUARDT, H
    STERNBERG, SS
    VIDAL, PM
    CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 177 - 181
  • [25] USE OF ADRIAMYCIN (NSC-123127) IN HEMATOLOGIC MALIGNANCIES
    WIERNIK, PH
    CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 369 - 373
  • [26] ADRIAMYCIN (NSC-123127) IN 87 PATIENTS WITH OSTEOSARCOMA
    CORTES, EP
    HOLLAND, JF
    WANG, JJ
    GLIDEWELL, O
    CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 305 - 313
  • [27] ADRIAMYCIN (NSC-123127) CARDIOTOXICITY - CLINICOPATHOLOGIC CORRELATION
    CORTES, EP
    LUTMAN, G
    WANKA, J
    WANG, JJ
    PICKREN, J
    WALLACE, J
    HOLLAND, JF
    CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 215 - 225
  • [28] CURRENT STATUS OF STUDIES WITH ADRIAMYCIN (NSC-123127)
    BACHUR, NR
    CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1973, 4 (03): : 47 - 50
  • [29] UNCOMMON SIDE-EFFECTS OF ADRIAMYCIN (NSC-123127)
    ETCUBANAS, E
    WILBUR, JR
    CANCER CHEMOTHERAPY REPORTS PART 1, 1974, 58 (06): : 757 - 758
  • [30] RATIONAL BASES FOR ADRIAMYCIN (NSC-123127) COMBINATION THERAPY
    HALL, TC
    CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 227 - 230